Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Causal Estimators in Meta-analysis with Missing Data Ruofan Bie Brown University NLST Oct 24, 2023 NLST-1146
Dietary inflammatory index and incidence of and death from ovarian cancer: A prospective study of American adults Qin Zhou The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China PLCO Oct 24, 2023 PLCO-1361
A Machine Learning Model to Identify Patients at Risk for Developing Small cell lung cancer Sinbad Xia The First Affiliated Hospital, School of Medicine, Zhejiang University PLCO Oct 24, 2023 PLCO-1363
Computer aided Diagnosis of Prostate Cancer using Multimodal Diagnostic Data Santosh Pattar KLE Technological University PLCO Oct 24, 2023 PLCOI-1359
Study of PSA Doubling Time (PSAdt) in pre-treatment men Hugh Mitchell Hugh Mitchell PLCO Oct 19, 2023 PLCO-1360
Risk Profile Assessment to Aid in Patient Selection Criteria for a Novel Lung Tissue Excision Tool in Lung Cancer Diagnosis and Intervention Lance Black Prana Thoracic NLST Oct 19, 2023 NLST-1142
Towards Explainable Deep Learning Model for Lung Nodule Diagnosis Chenglong Wang East China Normal University NLST Oct 19, 2023 NLST-1141
Adherence to a Low-carbohydrate Dietary Pattern Reduces Biliary Cancer Risk: Evidence from the PLCO Trial Rong Wang Zhongshan City People's Hospital PLCO Oct 17, 2023 PLCO-1357
Genomic Discovery: Therapeutic Targets for Non-Cancer Conditions Mary Black Foresite Labs PLCO Oct 16, 2023 PLCO-1356
Associations of BMI trajectories, weight gain, and the risk of pancreatic, biliary, liver and upper gi cancers Haiyang Peng Second Hospital Affiliated to Chongqing Medical University PLCO Oct 16, 2023 PLCO-1355
Identification and prediction of risk factors for upper gastrointestinal cancer bo zhu China Medical University PLCO Oct 16, 2023 PLCO-1350
Advancing Equity in Lung Cancer Screening Referrals: A Focus on Asian, Native, Alaskan, Hawaiian, and Pacific Islander Communities Amanda McCoy Lincoln Memorial University Debusk College of Osteopathic Medicine NLST Oct 10, 2023 NLST-1136
HANSE POST Jens Vogel-Clausen Hannover Medical School NLST Oct 10, 2023 NLST-1135
Development of lung cancer risk scores for determination of risk adapted screening intervals Rudolf Kaaks German Cancer Research Center (DKFZ) NLST Oct 10, 2023 NLST-1134
Comprehensive analyses of Fat Quality Index and incidence and mortality of lung cancer: A prospective cohort study Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO Oct 10, 2023 PLCO-1353
Investigation into the Effect of Dimensionality Reduction Techniques on Machine Learning Algorithm. Oluwaseun Ifekoya University of Hull PLCO Oct 5, 2023 PLCO-1349
Evolution of cancer stage and mortality in the PLCO trial Robert Schoen U. of Pittsburgh PLCO Oct 4, 2023 PLCO-1346
Addressing equity in lung cancer early detection through identification of high risk clinical and radiographic features in minority and disadvantaged patients. Ameen Salahudeen The Board of Trustees of the University of Illinois on behalf of The University of Illinois at Chicago. NLST Oct 3, 2023 NLST-1125
Development and validation of prognostic models of lung cancer following low-dose computed tomographic screening Fergus Imrie University of Cambridge NLST Oct 3, 2023 NLST-1132
Lung Cancer Research Md. Sultan Moheuddin East West University NLST Oct 3, 2023 NLST-1131